Trial Profile
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections; Infections; Pancreatitis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Dec 2008 New trial record.